Glucocorticoid dose determines osteocyte cell fate

Junjing Jia, Wei Yao, Min Guan, Weiwei Dai, Mohammad Shahnazari, Rekha Kar, Lynda Bonewald, Jean X. Jiang, Nancy E. Lane

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

In response to cellular insult, several pathways can be activated, including necrosis, apoptosis, and autophagy. Because glucocorticoids (GCs) have been shown to induce both osteocyte apoptosis and autophagy, we sought to determine whether osteocyte cell fate in the presence of GCs was dose dependent by performing in vivo and in vitro studies. Male Swiss-Webster mice were treated with slow-release prednisolone pellets at 1.4, 2.8, and 5.6 mg/kg/d for 28 d. An osteocyte cell line, MLO-Y4 cells, was treated with various doses of dexamethasone. We found that GC treatments dose dependently decreased activation of antioxidant-, autophagy-, and antiapoptosis-focused RT-PCR gene pathways in mouse cortical bone. The activation of antioxidant genes was correlated with autophagy gene expression after the GC treatments. The presence of osteocyte autophagy, as detected by immunostaining for LC3, increased ∼50% at the distal femur cortical bone region but not at trabecular bone region at the 1.4 and 2.8 mg/kg/d GC dose levels. The number of apoptotic osteocytes was increased at the cortical bone region by ∼40% initially observed at the 2.8 mg/kg/d dose level. In addition, the presence of the osteocyte autophagy was associated with an increased protein level of cathepsin K in vitro after the GC treatments. In summary, we found that GC treatment dose-dependently decreased antioxidant gene expression, with lower GC doses activating autophagy, whereas a higher dose increased apoptosis. These data suggest that autophagy may provide a mechanism for osteocytes to survive the stress after GC exposure and provide further insight into how GCs alter bone cell fate.

Original languageEnglish (US)
Pages (from-to)3366-3376
Number of pages11
JournalFASEB Journal
Volume25
Issue number10
DOIs
StatePublished - Oct 2011
Externally publishedYes

Fingerprint

Osteocytes
Glucocorticoids
Autophagy
Bone
Antioxidants
Apoptosis
Gene expression
Genes
Chemical activation
Cathepsin K
Gene Expression
Prednisolone
Femur
Dexamethasone
Transcriptional Activation
Necrosis
Cells
Bone and Bones

Keywords

  • Antioxidant
  • Apoptosis
  • Autophagy
  • LC3
  • MLO-Y4 cell
  • Osteoporosis

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology
  • Genetics
  • Molecular Biology

Cite this

Jia, J., Yao, W., Guan, M., Dai, W., Shahnazari, M., Kar, R., ... Lane, N. E. (2011). Glucocorticoid dose determines osteocyte cell fate. FASEB Journal, 25(10), 3366-3376. https://doi.org/10.1096/fj.11-182519

Glucocorticoid dose determines osteocyte cell fate. / Jia, Junjing; Yao, Wei; Guan, Min; Dai, Weiwei; Shahnazari, Mohammad; Kar, Rekha; Bonewald, Lynda; Jiang, Jean X.; Lane, Nancy E.

In: FASEB Journal, Vol. 25, No. 10, 10.2011, p. 3366-3376.

Research output: Contribution to journalArticle

Jia, J, Yao, W, Guan, M, Dai, W, Shahnazari, M, Kar, R, Bonewald, L, Jiang, JX & Lane, NE 2011, 'Glucocorticoid dose determines osteocyte cell fate', FASEB Journal, vol. 25, no. 10, pp. 3366-3376. https://doi.org/10.1096/fj.11-182519
Jia J, Yao W, Guan M, Dai W, Shahnazari M, Kar R et al. Glucocorticoid dose determines osteocyte cell fate. FASEB Journal. 2011 Oct;25(10):3366-3376. https://doi.org/10.1096/fj.11-182519
Jia, Junjing ; Yao, Wei ; Guan, Min ; Dai, Weiwei ; Shahnazari, Mohammad ; Kar, Rekha ; Bonewald, Lynda ; Jiang, Jean X. ; Lane, Nancy E. / Glucocorticoid dose determines osteocyte cell fate. In: FASEB Journal. 2011 ; Vol. 25, No. 10. pp. 3366-3376.
@article{ed6b948ebee84e4b9a1f191918f2cc4a,
title = "Glucocorticoid dose determines osteocyte cell fate",
abstract = "In response to cellular insult, several pathways can be activated, including necrosis, apoptosis, and autophagy. Because glucocorticoids (GCs) have been shown to induce both osteocyte apoptosis and autophagy, we sought to determine whether osteocyte cell fate in the presence of GCs was dose dependent by performing in vivo and in vitro studies. Male Swiss-Webster mice were treated with slow-release prednisolone pellets at 1.4, 2.8, and 5.6 mg/kg/d for 28 d. An osteocyte cell line, MLO-Y4 cells, was treated with various doses of dexamethasone. We found that GC treatments dose dependently decreased activation of antioxidant-, autophagy-, and antiapoptosis-focused RT-PCR gene pathways in mouse cortical bone. The activation of antioxidant genes was correlated with autophagy gene expression after the GC treatments. The presence of osteocyte autophagy, as detected by immunostaining for LC3, increased ∼50{\%} at the distal femur cortical bone region but not at trabecular bone region at the 1.4 and 2.8 mg/kg/d GC dose levels. The number of apoptotic osteocytes was increased at the cortical bone region by ∼40{\%} initially observed at the 2.8 mg/kg/d dose level. In addition, the presence of the osteocyte autophagy was associated with an increased protein level of cathepsin K in vitro after the GC treatments. In summary, we found that GC treatment dose-dependently decreased antioxidant gene expression, with lower GC doses activating autophagy, whereas a higher dose increased apoptosis. These data suggest that autophagy may provide a mechanism for osteocytes to survive the stress after GC exposure and provide further insight into how GCs alter bone cell fate.",
keywords = "Antioxidant, Apoptosis, Autophagy, LC3, MLO-Y4 cell, Osteoporosis",
author = "Junjing Jia and Wei Yao and Min Guan and Weiwei Dai and Mohammad Shahnazari and Rekha Kar and Lynda Bonewald and Jiang, {Jean X.} and Lane, {Nancy E.}",
year = "2011",
month = "10",
doi = "10.1096/fj.11-182519",
language = "English (US)",
volume = "25",
pages = "3366--3376",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "10",

}

TY - JOUR

T1 - Glucocorticoid dose determines osteocyte cell fate

AU - Jia, Junjing

AU - Yao, Wei

AU - Guan, Min

AU - Dai, Weiwei

AU - Shahnazari, Mohammad

AU - Kar, Rekha

AU - Bonewald, Lynda

AU - Jiang, Jean X.

AU - Lane, Nancy E.

PY - 2011/10

Y1 - 2011/10

N2 - In response to cellular insult, several pathways can be activated, including necrosis, apoptosis, and autophagy. Because glucocorticoids (GCs) have been shown to induce both osteocyte apoptosis and autophagy, we sought to determine whether osteocyte cell fate in the presence of GCs was dose dependent by performing in vivo and in vitro studies. Male Swiss-Webster mice were treated with slow-release prednisolone pellets at 1.4, 2.8, and 5.6 mg/kg/d for 28 d. An osteocyte cell line, MLO-Y4 cells, was treated with various doses of dexamethasone. We found that GC treatments dose dependently decreased activation of antioxidant-, autophagy-, and antiapoptosis-focused RT-PCR gene pathways in mouse cortical bone. The activation of antioxidant genes was correlated with autophagy gene expression after the GC treatments. The presence of osteocyte autophagy, as detected by immunostaining for LC3, increased ∼50% at the distal femur cortical bone region but not at trabecular bone region at the 1.4 and 2.8 mg/kg/d GC dose levels. The number of apoptotic osteocytes was increased at the cortical bone region by ∼40% initially observed at the 2.8 mg/kg/d dose level. In addition, the presence of the osteocyte autophagy was associated with an increased protein level of cathepsin K in vitro after the GC treatments. In summary, we found that GC treatment dose-dependently decreased antioxidant gene expression, with lower GC doses activating autophagy, whereas a higher dose increased apoptosis. These data suggest that autophagy may provide a mechanism for osteocytes to survive the stress after GC exposure and provide further insight into how GCs alter bone cell fate.

AB - In response to cellular insult, several pathways can be activated, including necrosis, apoptosis, and autophagy. Because glucocorticoids (GCs) have been shown to induce both osteocyte apoptosis and autophagy, we sought to determine whether osteocyte cell fate in the presence of GCs was dose dependent by performing in vivo and in vitro studies. Male Swiss-Webster mice were treated with slow-release prednisolone pellets at 1.4, 2.8, and 5.6 mg/kg/d for 28 d. An osteocyte cell line, MLO-Y4 cells, was treated with various doses of dexamethasone. We found that GC treatments dose dependently decreased activation of antioxidant-, autophagy-, and antiapoptosis-focused RT-PCR gene pathways in mouse cortical bone. The activation of antioxidant genes was correlated with autophagy gene expression after the GC treatments. The presence of osteocyte autophagy, as detected by immunostaining for LC3, increased ∼50% at the distal femur cortical bone region but not at trabecular bone region at the 1.4 and 2.8 mg/kg/d GC dose levels. The number of apoptotic osteocytes was increased at the cortical bone region by ∼40% initially observed at the 2.8 mg/kg/d dose level. In addition, the presence of the osteocyte autophagy was associated with an increased protein level of cathepsin K in vitro after the GC treatments. In summary, we found that GC treatment dose-dependently decreased antioxidant gene expression, with lower GC doses activating autophagy, whereas a higher dose increased apoptosis. These data suggest that autophagy may provide a mechanism for osteocytes to survive the stress after GC exposure and provide further insight into how GCs alter bone cell fate.

KW - Antioxidant

KW - Apoptosis

KW - Autophagy

KW - LC3

KW - MLO-Y4 cell

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=80053931553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053931553&partnerID=8YFLogxK

U2 - 10.1096/fj.11-182519

DO - 10.1096/fj.11-182519

M3 - Article

VL - 25

SP - 3366

EP - 3376

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 10

ER -